BSE filing, NSE: GLAXO. Summary written from the filing by ALFA Finder's alert engine.
GlaxoSmithKline Pharmaceuticals Ltd: key numbers
- Share price
- ₹2,518.90
- Market cap
- ₹42,672 Cr
- Revenue (annual)
- ₹3,822 Cr
- Net profit (annual)
- ₹1,036 Cr
- P/E (TTM)
- 40.0×Sector 46.1×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 4.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GlaxoSmithKline Pharmaceuticals Ltd
All →GlaxoSmithKline Pharmaceuticals Board Meeting Date
GlaxoSmithKline Pharmaceuticals Limited will hold a board meeting on 3rd November 2026 to consider and approve its unaudited financial results for the quarter ended 30th September 2026.
GlaxoSmithKline Pharmaceuticals Other Announcement
GlaxoSmithKline Pharmaceuticals Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI listing regulations.
GlaxoSmithKline Pharmaceuticals Annual General Meeting
GSK Pharma's postal ballot approved Ms. Natland as NED and Mr. Akshikar's MD re-appointment. Both resolutions cleared with over 99% shareholder support.
GlaxoSmithKline Pharmaceuticals Annual General Meeting
GlaxoSmithKline Pharmaceuticals issued a corrigendum for its August 3, 2026, postal ballot notice, correcting a typographical error in a reported salary figure.
GlaxoSmithKline Pharmaceuticals Price Movement Clarification
GlaxoSmithKline Pharmaceuticals clarified that recent trading volume increases are purely market-driven. The company confirmed all material disclosures have been made according to SEBI regulations.
GlaxoSmithKline Pharmaceuticals Business Update
GlaxoSmithKline Pharmaceuticals received an income tax refund intimation of Rs 4.99 Crore for the assessment year 2025-2026.
- Value
- ₹4.99 Cr
Other other announcement announcements
All →Infonative Solutions Other Announcement
Infonative Solutions reported nil investor complaints for the quarter ended 30 September 2026, as required under Regulation 13(3). This is compliance with no financial or business impact.
Fusion Klassroom Edutech Other Announcement
Fusion Klassroom Edutech filed its Reg 32 statement of IPO proceeds utilisation for the quarter and half year ended 30 September 2026. No deviation or variation is reported.
Parth Electricals & Engineering Other Announcement
Parth Electricals filed its fifth Monitoring Agency Report for the quarter ended September 30, 2026. It confirms no deviation from the issue objects.
KHFM Hospitality & Facility Management Services Other Announcement
KHFM filed a non-applicability notice for the Corporate Governance Report for the quarter ended 30 September 2026, with a practising CS certificate. This is routine compliance paperwork with no business or financial event.
Motilal Oswal Financial Services Other Announcement
Motilal Oswal Financial Services certifies utilisation of proceeds from listed Commercial Papers issued in the quarter ended September 30, 2026, and adherence to listing conditions. This is a periodic regulatory compliance certificate.
Invigorated Business Consulting Other Announcement
Invigorated Business Consulting appointed GAV & Associates as statutory auditor from 1 April 2027 for 60 months. The routine appointment carries no financial impact.
- Execution
- 60 months from 1 April 2027